HP007 / Huapu Bio - LARVOL DELTA

A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice. (PubMed, Front Cell Infect Microbiol) - "Rationally designed with key high-impact mutation sites, M5-RBD effectively overcomes SARS-CoV-2 variant immune evasion and elicits broad-spectrum neutralizing antibodies. The combination with HP007 adjuvant enhances immune protection, providing a promising strategy for the development of next-generation COVID-19 vaccines."

Journal • Preclinical • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases